C. Ramos

发表

Contemporary results of anatomic radical prostatectomy

W. Catalona, G. Carvalhal, C. Ramos, 1999, CA: a cancer journal for clinicians.

Lowering PSA cutoffs to enhance detection of curable prostate cancer.

W. Catalona, G. Carvalhal, C. Ramos, 2000, Urology.

Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening.

W. Catalona, D. Mager, Deborah S. Smith, 1999, The Journal of urology.

Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.

P. Humphrey, W. Catalona, C. Ramos, 2004, The Journal of urology.

Laparoscopic partial nephrectomy: A series of one hundred cases performed by the same surgeon

C. Ramos, J. Fullá, J. Campero, 2012, Urology annals.

Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer.

W. Catalona, D. Mager, Deborah S. Smith, 1999, The Journal of urology.

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features.

P. Humphrey, W. Catalona, Deborah S. Smith, 2002, Urology.

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.

William J Catalona, Misop Han, W. Catalona, 2004, The Journal of urology.

Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy

P. Humphrey, W. Catalona, G. Carvalhal, 2000, Cancer.

Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.

W. Catalona, D. Mager, Deborah S. Smith, 1999, The Journal of urology.

The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.

W. Catalona, D. Mager, C. Ramos, 1999, The Journal of urology.

TOTAL PSA CUTOFF OF 2.5 NG./ML. CORRELATES WITH FAVORABLE PATHOLOGIC FEATURES OF PROSTATE CANCER

P. Humphrey, W. Catalona, Deborah S. Smith, 1999 .

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.

C. Ramos, J. Fullá, C. Sánchez, 2013, Urologic oncology.

Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer.

W. Catalona, D. Mager, Deborah S. Smith, 1999, The Journal of urology.